Metraipolis › archive › dc_2f43cf47e99d

Clindamycin and intravenous immunoglobulins in pediatric invasive group A streptococcal disease: what is the evidence? — Europe PMC PMID:41714399

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41714399
DOI
10.1007/s00431-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-05T14:57:27.415Z
SHA-256 of the archived text
589d3f3db0fe8a525745832199b837df80d5f08485f1b7bc1cbe236abfa3f0fb
Stable URL of this page
https://metraipolis.com/documento/dc_2f43cf47e99d

How to cite

Clindamycin and intravenous immunoglobulins in pediatric invasive group A streptococcal disease: what is the evidence? — Europe PMC PMID:41714399 — Europe PMC (en), https://europepmc.org/article/MED/41714399 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f43cf47e99d (Metraipolis archive dc_2f43cf47e99d, sha256 589d3f3db0fe8a525745832199b837df80d5f08485f1b7bc1cbe236abfa3f0fb)
BibTeX
@misc{dc2f43cf47e99d,
  title = {Clindamycin and intravenous immunoglobulins in pediatric invasive group A streptococcal disease: what is the evidence? — Europe PMC PMID:41714399},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41714399},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f43cf47e99d; sha256 589d3f3db0fe8a525745832199b837df80d5f08485f1b7bc1cbe236abfa3f0fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41714399. Agents can read the archived copy with the MCP tool read_document.